Delivery Order SPE2DB22D3016-SPE2DB24FAGQ3
- Not listed
- This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Chlorothiazide Sodium 500 mg vials. The award amount is $3,739.78 and has an ultimate completion date of March 10, 2025. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price contract type. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,775.46, is for the delivery of chlorothiazide sodium 500 mg vials. The contract is a firm-fixed-price delivery order, with a period of performance through March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- The federal contract award SPE2DB22D6029|SPE2DB25FLTVX was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,538.40 firm fixed price delivery order is for 4,567,050,039 units of Chlorothiazide Sodium 500 mg vials. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,898.80 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with an ultimate completion date of January 7, 2026. This non-competitive delivery order was issued on January 6, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for...
- This federal contract award is for the delivery of CHLORDIAZEPOXIDE-CLIDINIUM CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $13,516.36 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025 with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $110,294.34, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. The contract has an ultimate completion date of October 10, 2023. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,456.75 Firm Fixed Price Delivery Order is for the supply of 4560815825 CHLORDIAZEPOXIDE-CLIDINIUM CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of May 4, 2023. The award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAGQ3Delivery Order
This federal contract award is for the delivery of Chlorothiazide Sodium 500 mg Vials, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,484.65, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of December 22, 2023. The contract was awarded on December 21, 2023, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 12/21/23 |